Insider Transactions in Q1 2026 at Janux Therapeutics, Inc. (JANX)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2026
|
Maria Dobek Vice President, Accounting |
BUY
Grant, award, or other acquisition
|
Direct |
18,935
+35.56%
|
-
|
|
Jan 02
2026
|
Maria Dobek Vice President, Accounting |
SELL
Open market or private sale
|
Direct |
1,462
-8.68%
|
$19,006
$13.73 P/Share
|
|
Jan 02
2026
|
Janeen Noel Doyle Chief Corp. & Bus. Dev. Ofcr |
BUY
Grant, award, or other acquisition
|
Direct |
36,000
+31.03%
|
-
|
|
Jan 02
2026
|
Zachariah Mc Iver Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,000
+35.68%
|
-
|
|
Jan 02
2026
|
Zachariah Mc Iver Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,714
-10.44%
|
$35,282
$13.73 P/Share
|
|
Jan 02
2026
|
Charles M. Winter Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,600
+21.2%
|
-
|
|
Jan 02
2026
|
Charles M. Winter Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
2,401
-3.0%
|
$31,213
$13.73 P/Share
|
|
Jan 02
2026
|
David Alan Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
96,600
+20.2%
|
-
|
|
Jan 02
2026
|
David Alan Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
8,072
-2.75%
|
$104,936
$13.73 P/Share
|
|
Jan 02
2026
|
Thomas Di Raimondo Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,400
+16.77%
|
-
|
|
Jan 02
2026
|
Thomas Di Raimondo Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,505
-1.97%
|
$32,565
$13.73 P/Share
|
|
Jan 02
2026
|
Andrew Hollman Meyer Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,879
-2.21%
|
$24,427
$13.73 P/Share
|